TY - JOUR
T1 - Seven decades of antipsychotic drugs
T2 - Why is the life of Australians with schizophrenia still so suboptimal?
AU - Castle, David
AU - Copolov, David
AU - Singh, Bruce
AU - Bastiampillai, Tarun
PY - 2024/3
Y1 - 2024/3
N2 - The advent of dopamine (D2) receptor-blocking medications over 70 years ago, ushered in a new era of biological treatment for schizophrenia. However, we argue that little subsequent progress has been made in translating this into fulfilled and fulfilling lives for people with schizophrenia. This Viewpoint asks why this is the case, and suggests ways forward for capitalising on extant and emerging new treatments for psychotic disorders, to the betterment of the lives of people living with schizophrenia.
AB - The advent of dopamine (D2) receptor-blocking medications over 70 years ago, ushered in a new era of biological treatment for schizophrenia. However, we argue that little subsequent progress has been made in translating this into fulfilled and fulfilling lives for people with schizophrenia. This Viewpoint asks why this is the case, and suggests ways forward for capitalising on extant and emerging new treatments for psychotic disorders, to the betterment of the lives of people living with schizophrenia.
KW - antipsychotics
KW - healthcare systems
KW - psychosocial care
KW - Schizophrenia
UR - http://www.scopus.com/inward/record.url?scp=85180495741&partnerID=8YFLogxK
U2 - 10.1177/00048674231209840
DO - 10.1177/00048674231209840
M3 - Article
C2 - 38130026
AN - SCOPUS:85180495741
SN - 0004-8674
VL - 58
SP - 201
EP - 206
JO - Australian and New Zealand Journal of Psychiatry
JF - Australian and New Zealand Journal of Psychiatry
IS - 3
ER -
